Navigation Links
Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimer's Disease
Date:10/15/2007

the trial did not meet the primary endpoint, we are encouraged by the favorable trend seen in the subgroup of subjects receiving cholinesterase inhibitors," said Stephen R. Murray, M.D., Ph.D., Chief Medical Officer. "Clearly there is a significant need for new options for the treatment of Alzheimer's disease, and we believe that the effects of MEM 1003 seen in this study warrant further investigation."

Subjects participating in the study were randomized at enrollment into one of three treatment groups -- 30 mg of MEM 1003 twice a day, 90 mg of MEM 1003 twice a day or placebo twice a day. During the double-blind treatment segment of the study, subjects received MEM 1003 or placebo for a period of 12 weeks, which was followed by a four-week single-blind placebo treatment. Secondary measures assessed changes in activities of daily living, behavior and global function.

MEM 1003 was generally well-tolerated in the trial. The rates of treatment-emergent adverse events were similar in all arms of the trial. There were seven treatment-emergent serious adverse events (SAEs) in five subjects, including two deaths. Four of the subjects were in the 30 mg dose group and the fifth subject was in the 90 mg dose group. None of the SAEs were deemed to be treatment-related by the investigators.

The Company expects to report top-line results from its Phase 2a clinical trial of MEM 3454, its lead nicotinic alpha-7 agonist, in Alzheimer's disease by the middle of the fourth quarter.

About MEM 1003

MEM 1003 is a neuronal L-type calcium channel modulator that Memory Pharmaceuticals is developing for the treatment of Alzheimer's disease. By blocking L-type calcium channels, MEM 1003 may regulate the flow of calcium and reestablish normal levels of calcium, which may help treat and prevent the onset of Alzheimer's disease.

Conference Call and Webcast Information

Memory Pharmaceuticals will hold a conference call on Monday, October 15, 2007, at 9:00
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 Today AmerisourceBergen, ... three new distribution centers in Olive Branch, ... and Newburgh, NY . The facilities ... ability to improve product access, increase supply chain efficiency ... is part of the company,s ongoing investments, more than ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 ... the addition of the "Electrophysiology Market by ... (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, Generator, ... Global Forecasts to 2019" report to their ... is estimated to grow at a significant CAGR ...
(Date:6/2/2015)... , June 2, 2015  Australian health technology ... AUD$14.8 million to rapidly progress the company,s ... KinetiGraph™ (PKG™) mobile health technology. ... further capital in the funding round. New ... high net worth individuals and also the ...
Breaking Medicine Technology:AmerisourceBergen to Build Three New Distribution Centers 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 3Global Kinetics Corporation Closes AUD$14.8 Million Capital Raising 2Global Kinetics Corporation Closes AUD$14.8 Million Capital Raising 3
... Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) ... webcast on Friday, September 17, 2010, at 7:00 a.m. ... Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs ... on September 16, 2010, to review the lorcaserin New ...
... Switzerland, and BANGALORE, India, Sept. 13 Debiopharm ... companies with a focus on the development of ... and Aurigene Discovery Technologies Ltd. (Aurigene), a Bangalore-based ... and peptide drug discovery and development from target ...
Cached Medicine Technology:Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting 2Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting 3Debiopharm Group™ and Aurigene Nominate Development Candidate 2Debiopharm Group™ and Aurigene Nominate Development Candidate 3
(Date:6/2/2015)... CA (PRWEB) June 02, 2015 ... has joined the firm in a newly created position ... accounts and support organizations committed to improving employee retention ... a wealth of marketing experience and most recently worked ... up that was recently taken over a global mobile ...
(Date:6/2/2015)... Camarillo, Calif. (PRWEB) June 02, 2015 ... designing and manufacturing high performance connector solutions and ... MINI-SNAP® advanced connector solutions to the US market. ... connector with Push-Pull locking capabilities. The self- securing ... range of demanding applications that require significant customization ...
(Date:6/2/2015)... Residents of Monarch Landing in Naperville ... a fitness class, do yoga, play volleyball, or participate ... for the Alzheimer’s Association’s Walk to End Alzheimer’s on ... part in a challenge to exercise for 60 days, ... company. , While the walk will raise awareness of ...
(Date:6/2/2015)... The Radiosurgery Society® (RSS), a ... RSSearch® Patient Registry evaluating the treatment patterns and ... the treatment of centrally located primary non-small cell ... The study, published in the May, 2015, issue ... patients with 114 centrally located lung tumors who ...
(Date:6/2/2015)... Colleen’s Dream Foundation , with fundraising ... the UNMC to support ovarian cancer research conducted by Cheng ... of the Colleen’s Dream Foundation Board of Directors. , Cundiff ... date for Colleen’s Dream Foundation and they couldn’t have picked ... Wang is a rising star in the ovarian cancer world,” ...
Breaking Medicine News(10 mins):Health News:Insightlink Communications Appoints New Director of Marketing and Client Engagement 2Health News:ODU Announces ODU MINI-SNAP® - Advanced Circular Connector Solution for Highly Customizable Applications 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 3Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 3Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3
... the research bolsters the idea that humans suffering from ... help preserve function by adding antioxidants to their diet, ... devised a new cell-based gene therapy technique that could ... these diseases. , The work, led by Scripps ...
... Corporation (Nasdaq: MASI ), the inventor of ... today announced that its management is scheduled to present ... Stock Conference at The Ritz-Carlton, Laguna Niguel in Dana ... a.m. PT. A live audiocast of the presentation will ...
... SOBeFiT Magazine, the first South Florida,publication dedicated to providing ... sports for men and women, will host its sold-out, ... presented by The Sports,Club/LA, as part of the series ... On February 8th, 2009, hundreds of ...
... not immediately order routine scans for low-back pain unless ... in the Oregon Evidence-Based Practice Center at Oregon Health ... this week,s edition of the The Lancet . ... scans in patients with low-back pain but no indication ...
... Corporation,(Nasdaq: VOLC ), a leader in the ... treatment of coronary and peripheral artery,disease, today announced that ... and all of fiscal 2008 on Tuesday, February 17. ... a conference call to discuss its financial results,and operating ...
... of its top priorities--reforming the nation,s health care system--twelve pharmacy stakeholder ... Reform, which will be announced during a media briefing on February ... ... Washington, DC (Vocus) February 6, 2009 -- As the new administration ...
Cached Medicine News:Health News:Team led by Scripps Scientists increases understanding of two types of blindness 2Health News:Team led by Scripps Scientists increases understanding of two types of blindness 3Health News:Team led by Scripps Scientists increases understanding of two types of blindness 4Health News:Team led by Scripps Scientists increases understanding of two types of blindness 5Health News:Masimo to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference 2Health News:SOBeFiT Magazine Promotes its Launch With First Annual 5K Run+Walk & Fitness Festival in South Beach 2Health News:SOBeFiT Magazine Promotes its Launch With First Annual 5K Run+Walk & Fitness Festival in South Beach 3Health News:Routine scans for low-back pain do not improve outcomes 2Health News:Routine scans for low-back pain do not improve outcomes 3Health News:Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast 2Health News:Pharmacy Stakeholder Groups Collaborate to Draft Pharmacy Principles for Health Care Reform 2Health News:Pharmacy Stakeholder Groups Collaborate to Draft Pharmacy Principles for Health Care Reform 3
Small golf club shape tip with sharp edge. Flat serrated handle with polished finish. Most popular size or model....
Threaded ends permit guarding the needle and gouge within the handle. Set consists of one each : E0828 A needle tip, E0828 B gauge tip and E0828 C handle. Most popular size or model....
0.5 mm replacement burr for Algerbrush rust ring remover (E0815 A). Burr can also be used with Algerbrush rust ring remover (E0815 B). Dull finish....
Short 12 mm taper with needle type tip. Stainless steel. Round smooth handle with polished finish. Overall length: 2.8 inches....
Medicine Products: